Pacira BioSciences: Q2 Earnings Insights


Pacira BioSciences PCRX reported its Q2 earnings results on Wednesday, August 3, 2022.

Here's what investors need to know about the announcement.


Pacira BioSciences missed estimated earnings by 42.05%, reporting an EPS of $0.51 versus an estimate of $0.88.

Revenue was up $33.82 million from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.19 which was followed by a 6.75% drop in the share price the next day.

Here's a look at Pacira BioSciences's past performance:


Quarter Q1 2022 Q4 2021 Q3 2021 Q2 2021
EPS Estimate 0.83 0.90 0.65 0.69
EPS Actual 0.64 0.97 0.72 0.77
Revenue Estimate 159.49M 155.74M 130.38M 128.01M
Revenue Actual 157.99M 159.19M 127.72M 135.59M

To track all earnings releases for Pacira BioSciences visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Market News and Data brought to you by Benzinga APIs
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: EarningsNewsBZI-Recaps
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!